SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-122366
Filing Date
2023-04-27
Accepted
2023-04-27 16:32:59
Documents
6

Document Format Files

Seq Description Document Type Size
1 DEFA14A d427637ddefa14a.htm DEFA14A 35328
2 GRAPHIC g427637sp0001.jpg GRAPHIC 16315
3 GRAPHIC g427637sp0001a.jpg GRAPHIC 24724
4 GRAPHIC g427637sp0001c.jpg GRAPHIC 3548
5 GRAPHIC g427637sp0001cn.jpg GRAPHIC 3135
6 GRAPHIC g427637sp0002.jpg GRAPHIC 958
  Complete submission text file 0001193125-23-122366.txt   104311
Mailing Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122
Business Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122 855-293-2639
BIORA THERAPEUTICS, INC. (Filer) CIK: 0001580063 (see all company filings)

IRS No.: 273950390 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39334 | Film No.: 23857670
SIC: 2834 Pharmaceutical Preparations